Poly-L-lactic Acid for Skin Quality



Status:Completed
Conditions:Cosmetic
Therapuetic Areas:Dermatology / Plastic Surgery
Healthy:No
Age Range:30 - 60
Updated:4/21/2016
Start Date:September 2013
End Date:September 2015

Use our guide to learn which trials are right for you!

Randomized, Controlled, Multi-Centered, Double-Blind Investigation of Injectable Poly-L-Lactic Acid (Sculptra Aesthetic) for Improving Facial Wrinkles and Skin Quality

Anecdotal evidence suggests that patients' skin quality may improve as a result of
poly-L-lactic acid injection. While this is not the primary goal of such treatments it is
often seen and described as so called "Sculptra glow".

The aim of this study is to evaluate the effect of repeated subcutaneous injections of
poly-L-lactic acid (Sculptra Aesthetic) on skin quality.

Participating subjects will be part of the study for about 15 months. There will be an
initial treatment period of up to 12 weeks, followed by a 12-month follow-up period. There
will be a total of 7 scheduled visits.

This study is a double-blind, randomized study. "Double-blind" means that neither the
subjects nor the study doctor will know who is receiving Sculptra Aesthetic or placebo.
"Randomized" means that the group subjects will be placed in is decided by chance, similar
to drawing numbers out of a hat or flipping a coin. Subjects will have a 1 out of 2 chance
of receiving the active study drug. After the completion of the study, if subjects are
assigned to the control (placebo) group they will receive free injections with Sculptra
Aesthetic same as the treatment group.


Inclusion Criteria:

- Subjects who are able to give voluntary, written informed consent to participate in
this study and from whom consent has been obtained including HIPAA authorization

- Healthy females between 30 and 60 years of age

- Subjects with Fitzpatrick photo skin types I-IV

- Subjects with shallow to deep nasolabial fold contour deficiencies or other facial
wrinkles

- Subjects who agree not to have any procedures affecting facial wrinkles (e.g. filler,
botulinum toxin, radiofrequency, laser, IPL, ultrasound) for the duration of the
study

- Subjects who do agree not to have any other procedures affecting skin quality
(microdermabrasion, peels, acne treatments, etc.) for the duration of the study

- Subjects who understand this study and are able to follow study instructions and are
willing to attend the required study visits

- Subjects who agree to be photographed for research reasons and their identity may not
be concealed in these photographs.

Exclusion Criteria:

- Subjects who are pregnant, planning to become pregnant or breastfeeding. A urine
pregnancy test will be done to rule out pregnancy

- Subjects of child-bearing potential who are not using an approved method of birth
control (oral contraceptives, IUD, contraceptive implant, barrier methods with
spermicide or abstinence). Females of non-childbearing potential are defined as
post-menopausal (absence of menstrual bleeding for one year), hysterectomy or
bilateral oophorectomy.

- Subjects who cannot understand or are not willing to comply with the requirements of
the study

- Subjects who have a known allergy to poly-L-lactic acid, carboxymethylcellulose,
non-pyrogenic mannitol or any anesthetic

- Subjects who have taken any NSAIDs (aspirin, ibuprofen, etc.) within 7 days before
treatment

- Subjects who have taken acetaminophen 24 hours before treatment

- Subjects who have had fillers or botulinum toxin in the treatment area in the past 12
months

- Subjects who have had treatments with poly-L-lactic acid in the face at any time

- Subjects who have had any kind of facial dermabrasion, chemical peel, laser, or IPL
treatment including superficial treatments for aesthetic reasons in the past 6 months
or for the duration of the study

- Subjects who does not agree to avoid using tanning beds or intensive exposure to the
sun 2 two weeks prior to each office visit.

- Subjects who have any dermatologic conditions including acne, rosacea, eczema,
psoriasis, actinic keratosis, severe sun damage, infection or scars within the
treatment area

- Subjects who have an active inflammatory process (skin eruptions such as cysts,
pimples, rashes or hives) or infection within the treatment area

- Subjects who have any known cancer including skin cancers (basal cell carcinoma,
squamous cell carcinoma and melanoma)

- Subjects who have had systemic corticosteroid therapy in the past 6 months or for the
duration of the study

- Subjects with a known history of poor wound healing

- Subjects with a known history of keloids (excessive scarring)

- Subjects who are HIV positive

- Subjects who have an existing medical condition that the Investigator considers may
put the subject at risk or compromise their participation in the study

- Subjects who have participated in another research study in the past 30 days

- Subjects who are currently involved in any injury litigation claims
We found this trial at
2
sites
911 Park Avenue
New York, New York 10075
212-710-9855
?
mi
from
New York, NY
Click here to add this to my saved trials
?
mi
from
Carmel, IN
Click here to add this to my saved trials